|
1
|
Sul J and Fine HA: Malignant gliomas: New
translational therapies. Mt Sinai J Med. 77:655–666. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martín V, Herrera F, Carrera-Gonzalez P,
García-Santos G, Antolín I, Rodriguez-Blanco J and Rodriguez C:
Intracellular signaling pathways involved in the cell growth
inhibition of glioma cells by melatonin. Cancer Res. 66:1081–1088.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang J and Hui CC: Hedgehog signaling in
development and cancer. Dev Cell. 15:801–812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ruiz i Altaba A: Gli proteins and Hedgehog
signaling: Development and cancer. Trends Genet. 15:418–425. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hui CC and Angers S: Gli proteins in
development and disease. Annu Rev Cell Dev Biol. 27:513–537. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bai CB, Auerbach W, Lee JS, Stephen D and
Joyner AL: Gli2, but not Gli1, is required for initial SHh
signaling and ectopic activation of the SHh pathway. Development.
129:4753–4761. 2002.PubMed/NCBI
|
|
7
|
Mo R, Freer AM, Zinyk DL, Crackower MA,
Michaud J, Heng HH, Chik KW, Shi XM, Tsui LC, Cheng SH, et al:
Specific and redundant functions of Gli2 and Gli3 zinc finger genes
in skeletal patterning and development. Development. 124:113–123.
1997.PubMed/NCBI
|
|
8
|
Brechbiel J, Miller-Moslin K and Adjei AA:
Crosstalk between hedgehog and other signaling pathways as a basis
for combination therapies in cancer. Cancer Treat Rev. 40:750–759.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Santoni M, Burattini L, Nabissi M, Morelli
MB, Berardi R, Santoni G and Cascinu S: Essential role of Gli
proteins in glioblastoma multiforme. Curr Protein Pept Sci.
14:133–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Karhadkar SS, Bova GS, Abdallah N, Dhara
S, Gardner D, Maitra A, Isaacs JT, Berman DM and Beachy PA:
Hedgehog signalling in prostate regeneration, neoplasia and
metastasis. Nature. 431:707–712. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee EY, Ji H, Ouyang Z, Zhou B, Ma W,
Vokes SA, McMahon AP, Wong WH and Scott MP: Hedgehog
pathway-regulated gene networks in cerebellum development and
tumorigenesis. Proc Natl Acad Sci USA. 107:9736–9741. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferruzzi P, Mennillo F, De Rosa A,
Giordano C, Rossi M, Benedetti G, Magrini R, Pericot Mohr G,
Miragliotta V, Magnoni L, et al: In vitro and in vivo
characterization of a novel Hedgehog signaling antagonist in human
glioblastoma cell lines. Int J Cancer. 131:E33–E44. 2012.
View Article : Google Scholar
|
|
13
|
Von Hoff DD, LoRusso PM, Rudin CM, Reddy
JC, Yauch RL, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, et
al: Inhibition of the hedgehog pathway in advanced basal-cell
carcinoma. N Engl J Med. 361:1164–1172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lauth M, Bergström A, Shimokawa T and
Toftgård R: Inhibition of GLI-mediated transcription and tumor cell
growth by small-molecule antagonists. Proc Natl Acad Sci USA.
104:8455–8460. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Varnat F, Duquet A, Malerba M, Zbinden M,
Mas C, Gervaz P and Ruiz i Altaba A: Human colon cancer epithelial
cells harbour active HEDGEHOG-GLI signalling that is essential for
tumour growth, recurrence, metastasis and stem cell survival and
expansion. EMBO Mol Med. 1:338–351. 2009. View Article : Google Scholar
|
|
16
|
Adams BD, Kasinski AL and Slack FJ:
Aberrant regulation and function of microRNAs in cancer. Curr Biol.
24:R762–R776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan R, Peng X, Yuan X, Huang D, Chen J, Lu
Q, Lv N and Luo S: Suppression of growth and migration by blocking
the Hedgehog signaling pathway in gastric cancer cells. Cell Oncol
(Dordr). 36:421–435. 2013. View Article : Google Scholar
|
|
20
|
Ciafrè SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, et al: miR-124 and miR-137 inhibit proliferation of
glioblastoma multiforme cells and induce differentiation of brain
tumor stem cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia H, Cheung WK, Ng SS, Jiang X, Jiang S,
Sze J, Leung GK, Lu G, Chan DT, Bian XW, et al: loss of
brain-enriched miR-124 microRNA enhances stem-like traits and
invasiveness of glioma cells. J Biol Chem. 287:9962–9971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goldenson B and Crispino JD: The aurora
kinases in cell cycle and leukemia. Oncogene. 34:537–545. 2015.
View Article : Google Scholar
|
|
24
|
Tang X, Deng L, Chen Q, Wang Y, Xu R, Shi
C, Shao J, Hu G, Gao M, Rao H, et al: Inhibition of Hedgehog
signaling pathway impedes cancer cell proliferation by promotion of
autophagy. Eur J Cell Biol. 94:223–233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Raver-Shapira N, Marciano E, Meiri E,
Spector Y, Rosenfeld N, Moskovits N, Bentwich Z and Oren M:
Transcriptional activation of miR-34a contributes to p53-mediated
apoptosis. Mol Cell. 26:731–743. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferretti E, De Smaele E, Miele E, Laneve
P, Po A, Pelloni M, Paganelli A, Di Marcotullio L, Caffarelli E,
Screpanti I, et al: Concerted microRNA control of Hedgehog
signalling in cerebellar neuronal progenitor and tumour cells. EMBO
J. 27:2616–2627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hyun J, Wang S, Kim J, Rao KM, Park SY,
Chung I, Ha CS, Kim SW, Yun YH and Jung Y: MicroRNA-378 limits
activation of hepatic stellate cells and liver fibrosis by
suppressing Gli3 expression. Nat Commun. 7:109932016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu F, Zheng Y, Hong W, Chen B, Dong P and
Zheng J: MicroRNA-200a suppresses epithelial-to-mesenchymal
transition in rat hepatic stellate cells via GLI family zinc finger
2. Mol Med Rep. 12:8121–8128. 2015.PubMed/NCBI
|
|
30
|
Jiang Z, Cushing L, Ai X and Lü J: miR-326
is downstream of Sonic hedgehog signaling and regulates the
expression of Gli2 and smoothened. Am J Respir Cell Mol Biol.
51:273–283. 2014.PubMed/NCBI
|
|
31
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen T, Wang XY, Li C and Xu SJ:
Downregulation of microRNA-124 predicts poor prognosis in glioma
patients. Neurol Sci. 36:131–135. 2015. View Article : Google Scholar
|
|
33
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peng XH, Huang HR, Lu J, Liu X, Zhao FP,
Zhang B, Lin SX, Wang L, Chen HH, Xu X, et al: MiR-124 suppresses
tumor growth and metastasis by targeting Foxq1 in nasopharyngeal
carcinoma. Mol Cancer. 13:1862014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Butz H, Szabó PM, Khella HW, Nofech-Mozes
R, Patocs A and Yousef GM: miRNA-target network reveals miR-124as a
key miRNA contributing to clear cell renal cell carcinoma
aggressive behaviour by targeting CAV1 and FLOT1. Oncotarget.
6:12543–12557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Glover DM, Leibowitz MH, McLean DA and
Parry H: Mutations in aurora prevent centrosome separation leading
to the formation of monopolar spindles. Cell. 81:95–105. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gautschi O, Heighway J, Mack PC, Purnell
PR, Lara PN Jr and Gandara DR: Aurora kinases as anticancer drug
targets. Clin Cancer Res. 14:1639–1648. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bischoff JR, Anderson L, Zhu Y, Mossie K,
Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, et
al: A homologue of Drosophila aurora kinase is oncogenic and
amplified in human colorectal cancers. EMBO J. 17:3052–3065. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Katayama H, Sasai K, Kawai H, Yuan ZM,
Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA and Sen
S: Phosphorylation by aurora kinase A induces Mdm2-mediated
destabilization and inhibition of p53. Nat Genet. 36:55–62. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tatsuka M, Sato S, Kitajima S, Suto S,
Kawai H, Miyauchi M, Ogawa I, Maeda M, Ota T and Takata T:
Overexpression of Aurora-A potentiates HRAS-mediated oncogenic
transformation and is implicated in oral carcinogenesis. Oncogene.
24:1122–1127. 2005. View Article : Google Scholar
|
|
41
|
Ma ZL, Zhang BJ, Wang DT, Li X, Wei JL,
Zhao BT, Jin Y, Li YL and Jin YX: Tanshinones suppress AURKA
through up-regulation of miR-32 expression in non-small cell lung
cancer. Oncotarget. 6:20111–20120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Z, Sun Y, Chen X, Squires J,
Nowroozizadeh B, Liang C and Huang J: p53 mutation directs AURKA
overexpression via miR-25 and FBXW7 in prostatic small cell
neuroendocrine carcinoma. Mol Cancer Res. 13:584–591. 2015.
View Article : Google Scholar :
|
